SE8603486L - INACTIVATION OF BACTERY ENDOTOXINES - Google Patents

INACTIVATION OF BACTERY ENDOTOXINES

Info

Publication number
SE8603486L
SE8603486L SE8603486A SE8603486A SE8603486L SE 8603486 L SE8603486 L SE 8603486L SE 8603486 A SE8603486 A SE 8603486A SE 8603486 A SE8603486 A SE 8603486A SE 8603486 L SE8603486 L SE 8603486L
Authority
SE
Sweden
Prior art keywords
bactery
endotoxines
inactivation
cytosylyl
guanylyl
Prior art date
Application number
SE8603486A
Other languages
Swedish (sv)
Other versions
SE8603486D0 (en
SE468626B (en
Inventor
A Gaffar
E J Coleman
Original Assignee
Colgate Palmolive Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Colgate Palmolive Co filed Critical Colgate Palmolive Co
Publication of SE8603486D0 publication Critical patent/SE8603486D0/en
Publication of SE8603486L publication Critical patent/SE8603486L/en
Publication of SE468626B publication Critical patent/SE468626B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/06Pyrimidine radicals
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/66Phosphorus compounds
    • A61K31/675Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07HSUGARS; DERIVATIVES THEREOF; NUCLEOSIDES; NUCLEOTIDES; NUCLEIC ACIDS
    • C07H19/00Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof
    • C07H19/02Compounds containing a hetero ring sharing one ring hetero atom with a saccharide radical; Nucleosides; Mononucleotides; Anhydro-derivatives thereof sharing nitrogen
    • C07H19/04Heterocyclic radicals containing only nitrogen atoms as ring hetero atom
    • C07H19/16Purine radicals

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Molecular Biology (AREA)
  • Biotechnology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)

Abstract

A non-toxic, water-soluble, pharmaceutically acceptable peroxydiphosphate compound is used to inhibit hypotensive shock and localised bone resorption caused by bacterial endotoxins. Preferred compounds are alkali metal, zinc, tin or quaternary ammonium salts or C1-12 alkyl, adenylyl, guanylyl, cytosylyl or thymylyl esters.
SE8603486A 1985-08-22 1986-08-19 APPLICATION OF A PEROXIDIFOSPHATE PHOTO SOCIETY FOR INHIBITATION OF HYPOTENSIVE SHOCK AND LOCAL BENRESORPTION SE468626B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US76839685A 1985-08-22 1985-08-22
US85191586A 1986-04-14 1986-04-14

Publications (3)

Publication Number Publication Date
SE8603486D0 SE8603486D0 (en) 1986-08-19
SE8603486L true SE8603486L (en) 1987-02-23
SE468626B SE468626B (en) 1993-02-22

Family

ID=27118049

Family Applications (1)

Application Number Title Priority Date Filing Date
SE8603486A SE468626B (en) 1985-08-22 1986-08-19 APPLICATION OF A PEROXIDIFOSPHATE PHOTO SOCIETY FOR INHIBITATION OF HYPOTENSIVE SHOCK AND LOCAL BENRESORPTION

Country Status (12)

Country Link
BE (1) BE905319A (en)
CA (1) CA1282004C (en)
CH (1) CH670046A5 (en)
DE (1) DE3627759A1 (en)
DK (1) DK168513B1 (en)
FR (1) FR2586351B1 (en)
GB (1) GB2180451B (en)
HK (1) HK593A (en)
IT (1) IT1196587B (en)
NL (1) NL8602140A (en)
SE (1) SE468626B (en)
SG (1) SG108892G (en)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR2586350B1 (en) * 1985-08-22 1992-05-15 Colgate Palmolive Co PHARMACEUTICAL COMPOSITION BASED ON PEROXODIPHOSPHATE FOR INHIBITION OF SECRETION OF PARATHYROIDIAN HORMONE
DE4201858A1 (en) * 1992-01-24 1993-07-29 Renschler Aloys Dr Med AGENT FOR TREATING MALIGNER CELLS
NO20024880L (en) * 2002-03-19 2003-09-22 Per Hamre Composition containing phosphate

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4041149A (en) * 1976-01-12 1977-08-09 Colgate-Palmolive Company Composition and method of controlling and preventing mouth odor
US4430325A (en) * 1981-12-23 1984-02-07 Colgate-Palmolive Company Topical treatment of skin lesions
US4975423A (en) * 1984-06-27 1990-12-04 Colgate-Palmolive Company Inhibition of tumor development
DK168191B1 (en) * 1984-06-27 1994-02-28 Colgate Palmolive Co Use of peroxydiphosphates for the preparation of pharmaceutical tablets or pharmaceutical aqueous solutions

Also Published As

Publication number Publication date
IT8648389A0 (en) 1986-08-19
SG108892G (en) 1992-12-24
DK402086D0 (en) 1986-08-22
HK593A (en) 1993-01-15
CH670046A5 (en) 1989-05-12
IT1196587B (en) 1988-11-16
NL8602140A (en) 1987-03-16
GB2180451B (en) 1989-10-18
DK402086A (en) 1987-02-23
BE905319A (en) 1987-02-23
SE8603486D0 (en) 1986-08-19
CA1282004C (en) 1991-03-26
GB8620482D0 (en) 1986-10-01
GB2180451A (en) 1987-04-01
DK168513B1 (en) 1994-04-11
DE3627759A1 (en) 1987-03-19
SE468626B (en) 1993-02-22
FR2586351B1 (en) 1991-10-18
FR2586351A1 (en) 1987-02-27

Similar Documents

Publication Publication Date Title
AU563093B2 (en) 8-chloro-1, 5-benzothiazepine derivatives
IL86837A (en) Repairing agent for cells and tissues containing as active ingredient an n-acetylneuraminic acid salt
ES8802148A1 (en) Quinolonecarboxylic acid derivatives.
ES2001341A6 (en) Novel guanidinomethylbenzoic acid derivatives.
ES2013403A6 (en) Process for the preparation of cephem derivatives and intermediates therefor.
EP0288969A3 (en) Antiulcer composition
SE8603486L (en) INACTIVATION OF BACTERY ENDOTOXINES
JPS6440479A (en) Piperidine derivative
ES468547A1 (en) Benzothiazepine compounds and compositions
GB2160525A (en) 8,10-dideazaminopterins
PH20505A (en) 1-acetonyl-2-(phenylimino)imidazolines and salts thereof and pharmaceutical compositions containing them
GB8405113D0 (en) N-arylpiperazine derivatives
IL58999A (en) Pharmaceutical compositions comprising certain 2-(n-phenylhydroxyamino)imidazoline derivatives
DE3851783D1 (en) Process for the preparation of 6- [D (-) - alpha- (4-ethyl-2,3-dioxo-1-piperazine-carboxamido) -phenylacetamido] penicillanic acid.
DE69405999D1 (en) PHARMACEUTICAL EFFECTIVE ENANTIOMERS
AU554372B2 (en) Dihydrothiazolo derivatives
GB1043853A (en) Improvements in or relating to diphenylsulphide compounds
ES8308335A1 (en) Antiviral deoxyuridine compounds.
DK74594A (en) Process for the preparation of paroxetine or a pharmaceutically acceptable salt thereof

Legal Events

Date Code Title Description
NAL Patent in force

Ref document number: 8603486-5

Format of ref document f/p: F

NUG Patent has lapsed

Ref document number: 8603486-5

Format of ref document f/p: F